Gold Nanoclusters Perform Enzyme-like Photocatalysis for Prodrug Activation
Source abstract
Abstract
Many synthetic nanomaterials known as nanozymes can catalyze biologically relevant molecular transformations just as natural enzyme does. “Photonanozyme” utilizes light as a spatial and temporal control for the regulation of nanozyme activities. Here we report a glutathione-modified gold nanocluster as a photonanozyme that catalyzes the reduction of nitrobenzene under light. Aniline was found as the sole photoreductive product. The photocatalytic reactions at variable light fluences were found to follow the classical Michaelis–Menten enzyme kinetics from which kinetic rate constants were quantified. Intracellular reduction of a nitro-group-containing fluorescent probe demonstrates the viability of gold nanoclusters as biocompatible photonanozymes performing catalysis in a mammalian cell environment. This study reinvents gold nanoclusters as photonanozymes that mimic naturally occurring nitroreductase for potential prodrug activation.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanocluster Synthesis and Applications · Advanced Nanomaterials in Catalysis · Gold and Silver Nanoparticles Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry, Fudan University, 220 Handan Road, Shanghai 200433, P. R. China
Funding
National Natural Science Foundation of China
References (27)
Show source-provided references
1. 10.1021/jacs.5b0409710.1021/jacs.5b04097 ↗
2. 10.1021/ja401360a10.1021/ja401360a ↗
3. 10.1039/D0SC04329J10.1039/D0SC04329J ↗
4. 10.1021/jacs.0c0162210.1021/jacs.0c01622 ↗
5. 10.1021/jacs.9b0083710.1021/jacs.9b00837 ↗
6. 10.1021/acs.chemrev.8b0049310.1021/acs.chemrev.8b00493 ↗
7. 10.1039/C9NR10822J10.1039/C9NR10822J ↗
8. 10.1002/anie.20180028810.1002/anie.201800288 ↗
9. 10.1021/acscatal.9b0286310.1021/acscatal.9b02863 ↗
10. 10.1021/ja505361n10.1021/ja505361n ↗
11. 10.1021/acs.jpclett.7b0159710.1021/acs.jpclett.7b01597 ↗
12. 10.1021/acsenergylett.8b0007010.1021/acsenergylett.8b00070 ↗
13. 10.1042/BJ2015065010.1042/BJ20150650 ↗
14. 10.1021/ja306199p10.1021/ja306199p ↗
15. 10.1021/jp410856h10.1021/jp410856h ↗
16. 10.1021/am100107k10.1021/am100107k ↗
17. 10.1021/acscatal.8b0400510.1021/acscatal.8b04005 ↗
18. 10.1021/jacs.5b1135310.1021/jacs.5b11353 ↗
19. 10.1021/jacs.5b0754010.1021/jacs.5b07540 ↗
20. 10.1021/jp101125j10.1021/jp101125j ↗
21. 10.1021/acscatal.0c0072510.1021/acscatal.0c00725 ↗
22. 10.1021/ja00851a03010.1021/ja00851a030 ↗
23. 10.1016/j.jhazmat.2007.02.02110.1016/j.jhazmat.2007.02.021 ↗
24. 10.1016/S0167-4838(98)00151-410.1016/S0167-4838(98)00151-4 ↗
25. 10.1021/ja501736510.1021/ja5017365 ↗
26. 10.1016/j.ccr.2020.21346010.1016/j.ccr.2020.213460 ↗
27. Chung-Faye G. · Clin. Cancer Res. · 2001 · 7 · 2662